Targeting the Tlr4–Md2 Complex with Coumarin Derivatives: Integrated In-Silico And In Vitro Evaluation of Scopoletin As A Potential Modulator of Nf-Κb Signalling in Diabetic Wound Healing

Authors

  • SWATI SWAGATIKA SWAIN Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Tamil Nadu-643001, India
  • VEERA VENKATA SATYANARAYANA REDDY KARRI Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Tamil Nadu-643001, India
  • GOWTHAMARAJAN KUPUSWAMY Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Tamil Nadu-643001, India
  • SRIKANTH JUPUDI Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Tamil Nadu-643001, India
  • SAGARKANTA MOHANTY Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Tamil Nadu-643001, India

DOI:

https://doi.org/10.22159/ijap.2026v18i5.59383

Keywords:

Diabetic wound, Inflammation, Macrophage polarization, TLR4-MD2

Abstract

Objective: This study aims to identify and evaluate coumarin derivatives as potential TLR4-MD2 (Toll-like receptor 4 -Myeloid differentiation factor 2) antagonists for diabetic wound healing via molecular docking studies, drug-likeness and ADMET properties, and in vitro evaluation of cytotoxic, antioxidant and anti-inflammatory activities.

Methods: Molecular docking of a library of coumarin derivatives was done against the TLR4 heterodimer (PDB ID: 3FXI) with the Schrodinger suite. Seven lead compounds (scopoletin, Dicoumarol, Osthole, Esculetin, Ayapin, Umbelliferone, and Daphnetin) were picked out of docking scores and interaction profiles to continue with their evaluation. SwissADME was used to evaluate drug-likeness properties and ADMET properties. MTT assay, DPPH radical scavenging assay, nitric oxide radicalscavenging assay, albumin denaturation assay and macrophage polarization by flow cytometry were performed.

Results: Among all the compounds that were tested, scopoletin showed the highest binding specificity (−7.670 kcal/mol) in the MD2 binding pocket, which is known to have strong hydrogen bonds and hydrophobic interactions with essential residues, and scopoletinmay be effectivefor inhibition of TLR4-mediated inflammatory signalling. In vitro experiments have revealed that scopoletin was not cytotoxic till 300 µM and exhibited good antioxidant properties with 91.3% DPPH radical scavenging (IC50: 109 µmol/L). Moreover, scopoletin had concentration-dependent nitric oxide radical scavenging (31.83% to 71.4%) and protein denaturation (47.03 % to 92.47 %).

Conclusion: These results indicate that scopoletinmay be a potential agent that has massive antioxidant and anti-inflammatory effects. Targeting TLR4-MD2 axis is a feature that indicates its potential as a therapeutic candidate in improving the diabetic wound healing,warranting further mechanistic validation.

References

1. Mohd S, Kumar LL, Harish V, Kumar R, Chaudhary A, Sharma V. Diabetes mellitus: Complications, emerging therapeutic targets, and evolving treatment approaches. Obesity Medicine. 2025 Nov 1;58:100652. doi:10.1016/j.obmed.2025.100652

2. McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW. Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers. Diabetes Care. 2023 Jan;46(1):209–21. doi:10.2337/dci22-0043 PubMed PMID: 36548709; PubMed Central PMCID: PMC9797649.

3. Huang K, Mi B, Xiong Y, Fu Z, Zhou W, Liu W, Liu G, Dai G. Angiogenesis during diabetic wound repair: from mechanism to therapy opportunity. Burns Trauma. 2025 Feb 7;13:tkae052. doi:10.1093/burnst/tkae052 PubMed PMID: 39927093; PubMed Central PMCID: PMC11802347.

4. Yan L, Wang J, Cai X, Liou Y, Shen H, Hao J, Huang C, Luo G, He W. Macrophage plasticity: signaling pathways, tissue repair, and regeneration. MedComm (2020). 2024 Aug 1;5(8):e658. doi:10.1002/mco2.658 PubMed PMID: 39092292; PubMed Central PMCID: PMC11292402.

5. Ma M, Jiang W, Zhou R. DAMPs and DAMP-sensing receptors in inflammation and diseases. Immunity. 2024 Apr 9;57(4):752–71. doi:10.1016/j.immuni.2024.03.002

6. Asami J, Shimizu T. Structural and functional understanding of the toll‐like receptors. Protein Sci. 2021 Apr;30(4):761–72. doi:10.1002/pro.4043 PubMed PMID: 33576548; PubMed Central PMCID: PMC7980524.

7. Wang K, Huang H, Zhan Q, Ding H, Li Y. Toll‐like receptors in health and disease. MedComm (2020). 2024 Apr 29;5(5):e549. doi:10.1002/mco2.549 PubMed PMID: 38685971; PubMed Central PMCID: PMC11057423.

8. Lucas K, Maes M. Role of the Toll Like Receptor (TLR) Radical Cycle in Chronic Inflammation: Possible Treatments Targeting the TLR4 Pathway. Mol Neurobiol. 2013 Aug;48(1):190–204. doi:10.1007/s12035-013-8425-7

9. Sun D, Chang Q, Lu F. Immunomodulation in diabetic wounds healing: The intersection of macrophage reprogramming and immunotherapeutic hydrogels. J Tissue Eng. 2024 Jul 27;15:20417314241265202. doi:10.1177/20417314241265202 PubMed PMID: 39071896; PubMed Central PMCID: PMC11283672.

10. Kumar A, P N, Kumar M, Jose A, Tomer V, Oz E, Proestos C, Zeng M, Elobeid T, K S, Oz F. Major Phytochemicals: Recent Advances in Health Benefits and Extraction Method. Molecules. 2023 Jan 16;28(2):887. doi:10.3390/molecules28020887 PubMed PMID: 36677944; PubMed Central PMCID: PMC9862941.

11. Singh S, Sharma N. Evaluation of wound healing activity of Acacia auriculiformis A. Cunn. stem bark. Asian Journal of Pharmaceutical and Clinical Research. 2014 Jan 1;7:204–7.

12. Gandhi GR, Mohana T, Athesh K, Hillary VE, Vasconcelos ABS, Farias de Franca MN, Montalvão MM, Ceasar SA, Jothi G, Sridharan G, Gurgel RQ, Xu B. Anti-inflammatory natural products modulate interleukins and their related signaling markers in inflammatory bowel disease: A systematic review. Journal of Pharmaceutical Analysis. 2023 Dec 1;13(12):1408–28. doi:10.1016/j.jpha.2023.09.012

13. S. J, Murthy S, Ramesh R. EVALUATION OF THE WOUND HEALING ACTIVITY OF CAESALPINIA BONDUCELLA AND CYCLEA PELTATA EXTRACTS IN EXPERIMENTALLY INDUCED DIABETIC RATS. International Journal of Pharmacy and Pharmaceutical Sciences. 2017 Oct 2;9:211. doi:10.22159/ijpps.2017v9i10.19788

14. Majnooni MB, Fakhri S, Smeriglio A, Trombetta D, Croley CR, Bhattacharyya P, Sobarzo-Sánchez E, Farzaei MH, Bishayee A. Antiangiogenic Effects of Coumarins against Cancer: From Chemistry to Medicine. Molecules. 2019 Nov 24;24(23):4278. doi:10.3390/molecules24234278 PubMed PMID: 31771270; PubMed Central PMCID: PMC6930449.

15. Wang L, Yang K, Xie X, Wang S, Gan H, Wang X, Wei H. Macrophages as Multifaceted Orchestrators of Tissue Repair: Bridging Inflammation, Regeneration, and Therapeutic Innovation. J Inflamm Res. 2025 Jul 8;18:8945–59. doi:10.2147/JIR.S527764 PubMed PMID: 40655959; PubMed Central PMCID: PMC12255350.

16. Chen K, Shi K, Jin T, Lu S, Yin W. Computational Identification and Anti-Inflammatory Evaluation of T19093 as a TLR4/MD2 Inhibitor. Curr Top Med Chem. 2025;25(26):3068–81. doi:10.2174/0115680266345918250212144023 PubMed PMID: 39976020; PubMed Central PMCID: PMC12728533.

17. Margaryan S, Poghosyan D, Ghonyan S, Hakobyan L, Martirosyan A, Manukyan G. Long-term hyperglycaemia exerts contrasting effects on M1- and M2-like macrophages. Front Immunol. 2025 Jul 31;16:1639650. doi:10.3389/fimmu.2025.1639650 PubMed PMID: 40821781; PubMed Central PMCID: PMC12350303.

18. Kim HJ, Kim H, Lee JH, Hwangbo C. Toll-like receptor 4 (TLR4): new insight immune and aging. Immun Ageing. 2023 Nov 24;20:67. doi:10.1186/s12979-023-00383-3 PubMed PMID: 38001481; PubMed Central PMCID: PMC10668412.

19. Larouche J, Sheoran S, Maruyama K, Martino MM. Immune Regulation of Skin Wound Healing: Mechanisms and Novel Therapeutic Targets. Adv Wound Care (New Rochelle). 2018 Jul 1;7(7):209–31. doi:10.1089/wound.2017.0761 PubMed PMID: 29984112; PubMed Central PMCID: PMC6032665.

20. Jangid H, Shah NH, Dar MA, Wani AK. Identification of potent phytochemical inhibitors against mobilized colistin resistance: Molecular docking, MD simulations, ADMET, and toxicity predictions. In Silico Research in Biomedicine. 2025 Jan 1;1:100013. doi:10.1016/j.insi.2025.100013

21. Tiwari R, Pathak K. Local Drug Delivery Strategies towards Wound Healing. Pharmaceutics. 2023 Feb 13;15(2):634. doi:10.3390/pharmaceutics15020634 PubMed PMID: 36839956; PubMed Central PMCID: PMC9964694.

22. Tang J, Li X, Wang H, Mai R, Xie M, Tang Y, Huang W, Zhao D, Xiang L. Application and Prospects of Smart Dressings in Wound Healing. ACS Appl Mater Interfaces. 2025 Oct 8;17(40):55808–32. doi:10.1021/acsami.5c16246

23. Zhang Y, Liu H, Jia W, Qi J, Zhang W, Zhang W, Liang G, Zhang Y, Chen H. Myeloid Differentiation Protein 2 Mediates Angiotensin II-Induced Liver Inflammation and Fibrosis in Mice. Molecules. 2020 Jan;25(1):25. doi:10.3390/molecules25010025

24. Fu Y, Kim H, Lee DS, Han A reum, Heine H, Zamyatina A, Kim HM. Structural insight into TLR4/MD-2 activation by synthetic LPS mimetics with distinct binding modes. Nat Commun. 2025 May 5;16:4164. doi:10.1038/s41467-025-59550-3 PubMed PMID: 40325026; PubMed Central PMCID: PMC12053604.

25. Kumar S, Kumar BH, Nayak R, Pandey S, Kumar N, Pai KSR. Computational screening and molecular dynamics of natural compounds targeting the SH2 domain of STAT3: a multitarget approach using network pharmacology. Mol Divers. 2025;29(6):5607–33. doi:10.1007/s11030-024-11075-5 PubMed PMID: 39786519; PubMed Central PMCID: PMC12638358.

26. Sahayarayan JJ, Rajan KS, Vidhyavathi R, Nachiappan M, Prabhu D, Alfarraj S, Arokiyaraj S, Daniel AN. In-silico protein-ligand docking studies against the estrogen protein of breast cancer using pharmacophore based virtual screening approaches. Saudi J Biol Sci. 2021 Jan;28(1):400–7. doi:10.1016/j.sjbs.2020.10.023 PubMed PMID: 33424323; PubMed Central PMCID: PMC7785421.

27. Verma S, Reddy P, Sowdhamini R. Integrated approaches for the recognition of small molecule inhibitors for Toll-like receptor 4. Computational and Structural Biotechnology Journal. 2023 Jan 1;21:3680–9. doi:10.1016/j.csbj.2023.07.026

28. D’Aloia A, Arrigoni F, Tisi R, Palmioli A, Ceriani M, Artusa V, Airoldi C, Zampella G, Costa B, Cipolla L. Synthesis, Molecular Modeling and Biological Evaluation of Metabolically Stable Analogues of the Endogenous Fatty Acid Amide Palmitoylethanolamide. International Journal of Molecular Sciences. 2020 Jan;21(23):9074. doi:10.3390/ijms21239074

29. Kim J, Jin H, Kim J, Cho SY, Moon S, Wang J, Mao J, No KT. Leveraging the Fragment Molecular Orbital and MM-GBSA Methods in Virtual Screening for the Discovery of Novel Non-Covalent Inhibitors Targeting the TEAD Lipid Binding Pocket. Int J Mol Sci. 2024 May 14;25(10):5358. doi:10.3390/ijms25105358 PubMed PMID: 38791396; PubMed Central PMCID: PMC11121470.

30. Vasudevan S, Chattaraj S, Enrico A, Pasqualini FS. Molecular Dynamics Simulation of Structural Assembly and Hydration of Hyaluronic Acid in Salt Aqueous Buffer. Langmuir. 2025 Feb 18;41(6):3852–64. doi:10.1021/acs.langmuir.4c03966

31. Pavan M, Menin S, Bassani D, Sturlese M, Moro S. Qualitative Estimation of Protein–Ligand Complex Stability through Thermal Titration Molecular Dynamics Simulations. J Chem Inf Model. 2022 Nov 28;62(22):5715–28. doi:10.1021/acs.jcim.2c00995

32. Yan S, Peck JM, Ilgu M, Nilsen-Hamilton M, Lamm MH. Sampling Performance of Multiple Independent Molecular Dynamics Simulations of an RNA Aptamer. ACS Omega. 2020 Aug 18;5(32):20187–201. doi:10.1021/acsomega.0c01867

33. Pieroni M, Madeddu F, Di Martino J, Arcieri M, Parisi V, Bottoni P, Castrignanò T. MD–Ligand–Receptor: A High-Performance Computing Tool for Characterizing Ligand–Receptor Binding Interactions in Molecular Dynamics Trajectories. International Journal of Molecular Sciences. 2023 Jan;24(14):11671. doi:10.3390/ijms241411671

34. Trinh TT, Fadriquela A, Bajgai J, Sharma S, Rahman MH, Goh SH, Khang SS, Khang WR, Kim CS, Lee KJ. Anti-Oxidative Effect of Weak Alkaline Reduced Water in RAW 264.7 Murine Macrophage Cells. Processes. 2021 Nov;9(11):2062. doi:10.3390/pr9112062

35. Kang M jae, Choi W, Yoo SH, Nam SW, Shin PG, Kim KK, Kim GD. Modulation of Inflammatory Pathways and Adipogenesis by the Action of Gentisic Acid in RAW 264.7 and 3T3-L1 Cell Lines. J Microbiol Biotechnol. 2021 Aug 28;31(8):1079–87. doi:10.4014/jmb.2105.05004 PubMed PMID: 34226400; PubMed Central PMCID: PMC9705943.

36. Bibi Sadeer N, Montesano D, Albrizio S, Zengin G, Mahomoodally MF. The Versatility of Antioxidant Assays in Food Science and Safety—Chemistry, Applications, Strengths, and Limitations. Antioxidants. 2020 Aug;9(8):709. doi:10.3390/antiox9080709

37. Middha SK, Goyal AK, Lokesh P, Yardi V, Mojamdar L, Keni DS, Babu D, Usha T. Toxicological Evaluation of Emblica officinalis Fruit Extract and its Anti-inflammatory and Free Radical Scavenging Properties. Pharmacogn Mag. 2015 Oct;11(Suppl 3):S427–33. doi:10.4103/0973-1296.168982 PubMed PMID: 26929577; PubMed Central PMCID: PMC4745213.

38. Montana G, Lampiasi N. Substance P Induces HO-1 Expression in RAW 264.7 Cells Promoting Switch towards M2-Like Macrophages. PLoS One. 2016 Dec 1;11(12):e0167420. doi:10.1371/journal.pone.0167420 PubMed PMID: 27907187; PubMed Central PMCID: PMC5132328.

39. Brizzolari A, Dei Cas M, Cialoni D, Marroni A, Morano C, Samaja M, Paroni R, Rubino FM. High-Throughput Griess Assay of Nitrite and Nitrate in Plasma and Red Blood Cells for Human Physiology Studies under Extreme Conditions. Molecules. 2021 Jul 28;26(15):4569. doi:10.3390/molecules26154569 PubMed PMID: 34361720; PubMed Central PMCID: PMC8348835.

40. Wen Q, Paik DC. Using the Griess colorimetric nitrite assay for measuring aliphatic β-nitroalcohols. Exp Eye Res. 2012 May;98(1):52–7. doi:10.1016/j.exer.2012.01.014 PubMed PMID: 22406005; PubMed Central PMCID: PMC3373252.

41. Zaouani M, Bitam A, Baz A, Benali Y, BEN-MAHDI M. In vivo evaluation of wound healing and anti-inflammatory activity of methanolic extract of roots of Centaurea africana (L.) in topical formulation. Asian Journal of Pharmaceutical and Clinical Research. 2017 Jan 1;10:341–6. doi:10.22159/ajpcr.2017.v10i1.15436

42. M A, I MA, Ramalingam K, S R. Evaluation of the Anti-inflammatory, Antimicrobial, Antioxidant, and Cytotoxic Effects of Chitosan Thiocolchicoside-Lauric Acid Nanogel. Cureus. 15(9):e46003. doi:10.7759/cureus.46003 PubMed PMID: 37900405; PubMed Central PMCID: PMC10600588.

43. Anjum AS, Varghese SS, Rajeshkumar S. In vitro Anti Inflammatory Activity of Abies webbiana Using Albumin Denaturation Assay. Journal of Pharmaceutical Research International. 2021 Dec 29;312–21. doi:10.9734/jpri/2021/v33i63B35642

44. Carpenter KA, Altman RB. Databases of ligand-binding pockets and protein-ligand interactions. Computational and Structural Biotechnology Journal. 2024 Dec 1;23:1320–38. doi:10.1016/j.csbj.2024.03.015

45. Shaikh F, Siu SWI. Identification of novel natural compound inhibitors for human complement component 5a receptor by homology modeling and virtual screening. Med Chem Res. 2016;25:1564–73. doi:10.1007/s00044-016-1591-1 PubMed PMID: 27499603; PubMed Central PMCID: PMC4958400.

46. Du YN, Yan JN, Xu SQ, Liu HX, Wang YQ, Lai B, Wang C, Wu HT. Gelation properties and molecular dynamics simulation of thermally induced large yellow croaker (Pseudosciaena crocea) roe protein isolate gels. LWT. 2023 Nov 1;189:115393. doi:10.1016/j.lwt.2023.115393

47. Trezza A, Visibelli A, Roncaglia B, Barletta R, Iannielli S, Mahboob L, Spiga O, Santucci A. Unveiling Dynamic Hotspots in Protein–Ligand Binding: Accelerating Target and Drug Discovery Approaches. Int J Mol Sci. 2025 Apr 23;26(9):3971. doi:10.3390/ijms26093971 PubMed PMID: 40362212; PubMed Central PMCID: PMC12071544.

48. Madorran E, Stožer A, Arsov Z, Maver U, Rožanc J. A Promising Method for the Determination of Cell Viability: The Membrane Potential Cell Viability Assay. Cells. 2022 Jul 27;11(15):2314. doi:10.3390/cells11152314 PubMed PMID: 35954159; PubMed Central PMCID: PMC9367465.

49. Ghasemi M, Turnbull T, Sebastian S, Kempson I. The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis. Int J Mol Sci. 2021 Nov 26;22(23):12827. doi:10.3390/ijms222312827 PubMed PMID: 34884632; PubMed Central PMCID: PMC8657538.

Published

2026-06-29

How to Cite

SWAGATIKA SWAIN, S., SATYANARAYANA REDDY KARRI, V. V., KUPUSWAMY, G., JUPUDI, S., & MOHANTY, S. (2026). Targeting the Tlr4–Md2 Complex with Coumarin Derivatives: Integrated In-Silico And In Vitro Evaluation of Scopoletin As A Potential Modulator of Nf-Κb Signalling in Diabetic Wound Healing. International Journal of Applied Pharmaceutics, 18(5). https://doi.org/10.22159/ijap.2026v18i5.59383

Issue

Section

Original Article(s)

Most read articles by the same author(s)

Similar Articles

<< < 1 2 3 4 5 > >> 

You may also start an advanced similarity search for this article.